clinical trial transparency

Can you comply your way to greatness?

by Sarah Lyons – Senior Director, Operations I recently heard something that stuck with me: “Nobody complies their way to…

Early Impact of Health Canada’s New Guidelines

Sarah Lyons – Senior Director, Operations Health Canada has introduced new regulatory guidance for anonymizing clinical study reports. As background,…

Clinical Trial Disclosure and Data Transparency Conference

We look forward to seeing you at the DIA Clinical Trial Disclosure and Data Transparency Conference! Clinical trial information transparency…

Publication and Clinical Trials Transparency

With more stringent focus on posting results publicly, it is a necessity to align the registration process, results release, report…

Achieving Clinical Trials Transparency

Recent policy changes by Europe’s regulatory authority for drugs and devices has rekindled the pharmaceutical industry’s focus on clinical trials…

Methods for Risk-based De-id of CSRs

Clinical study reports have a wealth of insight – unlock it with a risk-based de-identification strategy. This webinar explores how to accomplish this.

Responsible De-identification of Clinical Trial Data

Best practices around clinical trial data sharing The number of clinical trial data sets that are available for secondary analysis…

Free Webinar: De-Identification 101

Join Privacy Analytics for a high level introduction of de-identification and data masking.
Watch now

Free Download: De-Id 101

You have Successfully Subscribed!